Home › NDC Lookup › RxCUI directory › RxCUI 542347

Isoflurane 999 MG/ML Inhalation Solution — RxCUI 542347

RxNorm drug concept · Semantic clinical drug
RxCUI 542347 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 16 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI542347
Official nameIsoflurane 999 MG/ML Inhalation Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asisoflurane 99.9 % Inhalation Solution
FDA products mapped10
Package NDCs mapped16
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Isoflurane 999 MG/ML Inhalation Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Isoflurane 999 MG/ML Inhalation Solution RxCUI 542347

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Isoflurane 6026
  2. Brand names 5

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Fluriso 1540980
    • Forane 92754
    • IsoSol 1549859
    • Isospire 2628927
    • Terrell 542352
  3. Dose forms 14

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Isoflurane Inhalation Solution 2108461
    • Isoflurane Inhalant Product 1159154
    • Isoflurane Inhalation Solution [Fluriso] 2108465
    • Isoflurane Inhalation Solution [Forane] 2108467
    • Isoflurane Inhalation Solution [IsoSol] 2108471
    • Isoflurane Inhalation Solution [Isospire] 2628930
    • Isoflurane Inhalation Solution [Terrell] 2108475
    • Fluriso Inhalant Product 1540983
    • +6 more in this family
  4. Clinical & branded drugs 11

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 22 of 31 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Isoflurane 999 MG/ML SCDC · 542346
  • Isoflurane Inhalation Solution SCDF · 2108461
  • Isoflurane Inhalant Product SCDG · 1159154

Brand-Name Concepts

  • Isoflurane 999 MG/ML Inhalation Solution [Forane] SBD · 542358
  • Isoflurane 999 MG/ML Inhalation Solution [Terrell] SBD · 542355
  • Isoflurane 999 MG/ML Inhalation Solution [Fluriso] SBD · 1540984
  • Isoflurane 999 MG/ML Inhalation Solution [IsoSol] SBD · 1549863
  • Isoflurane 999 MG/ML Inhalation Solution [Isospire] SBD · 2628931
  • Isoflurane 999 MG/ML [Fluriso] SBDC · 1540981
  • Isoflurane 999 MG/ML [Forane] SBDC · 542356
  • Isoflurane 999 MG/ML [IsoSol] SBDC · 1549860
  • Isoflurane 999 MG/ML [Isospire] SBDC · 2628928
  • Isoflurane 999 MG/ML [Terrell] SBDC · 542353

📦 FDA Products & Package NDCs

10 products · 16 package NDCs
16 package NDCs map to RxCUI 542347 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10019-0360-40 6 BOTTLE, GLASS in 1 PACKAGE (10019-360-40) / 100 mL in 1 B... FORANE Baxter Healthcare Corporation 1979-12-18
10019-0360-60 6 BOTTLE, GLASS in 1 PACKAGE (10019-360-60) / 250 mL in 1 B... FORANE Baxter Healthcare Corporation 1979-12-18
12164-0012-10 100 mL in 1 BOTTLE, GLASS (12164-012-10) Isoflurane Halocarbon Life Sciences, LLC 1999-10-20
12164-0012-25 250 mL in 1 BOTTLE, GLASS (12164-012-25) Isoflurane Halocarbon Life Sciences, LLC 1999-10-20
42677-0326-01 1 BOTTLE, GLASS in 1 CARTON (42677-326-01) / 100 mL in 1 BO... Isoflurane Shandong New Time Pharmaceutical Co., Ltd. 2025-11-04
42677-0327-01 1 BOTTLE, GLASS in 1 CARTON (42677-327-01) / 250 mL in 1 BO... Isoflurane Shandong New Time Pharmaceutical Co., Ltd. 2025-11-04
66794-0011-10 100 mL in 1 BOTTLE, GLASS (66794-011-10) Terrell Piramal Critical Care, Inc. 2010-02-28
66794-0011-25 250 mL in 1 BOTTLE, GLASS (66794-011-25) Terrell Piramal Critical Care, Inc. 2010-02-28
66794-0017-10 100 mL in 1 BOTTLE, GLASS (66794-017-10) Isoflurane Piramal Critical Care, Inc. 2011-10-07
66794-0017-25 250 mL in 1 BOTTLE, GLASS (66794-017-25) Isoflurane Piramal Critical Care, Inc. 2011-10-07
66794-0019-10 100 mL in 1 BOTTLE, GLASS (66794-019-10) Terrell Piramal Critical Care Inc 2012-03-21
66794-0019-25 250 mL in 1 BOTTLE, GLASS (66794-019-25) Terrell Piramal Critical Care Inc 2012-03-21
66794-0020-10 100 mL in 1 BOTTLE (66794-020-10) Isoflurane Piramal Critical Care, Inc. 2013-11-13
66794-0020-25 250 mL in 1 BOTTLE, GLASS (66794-020-25) Isoflurane Piramal Critical Care, Inc. 2013-11-13
83301-0071-02 6 BOTTLE, GLASS in 1 CASE (83301-0071-2) / 100 mL in 1 BOTT... Isoflurane, (Volatile for Inhalation) Mullan Pharmaceutical Inc. 2026-04-01
83301-0072-02 6 BOTTLE, GLASS in 1 CASE (83301-0072-2) / 250 mL in 1 BOTT... Isoflurane, (Volatile for Inhalation) Mullan Pharmaceutical Inc. 2026-04-01
Observed labelers: Piramal Critical Care, Inc. (6) · Baxter Healthcare Corporation (2) · Halocarbon Life Sciences, LLC (2) · Mullan Pharmaceutical Inc. (2) · Piramal Critical Care Inc (2) · Shandong New Time Pharmaceutical Co., Ltd. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.